文献速递腹部MR

钆塞酸增强MRI功能肝成像评分(FLIS)在慢性肝病和肝硬化患者中的验证:Child-Pugh评分与FLIS的关系

Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
PubMed 文献 · Eur Radiol · 2021-04-21

本研究回顾性纳入134例慢性肝病或肝硬化患者,评估钆塞酸增强MRI肝胆期三个参数衍生的功能肝成像评分(FLIS)与Child-Pugh(CP)评分的相关性。结果显示FLIS与CP评分强相关,FLIS≥5是预测CP A级或慢性肝病的最佳阈值(敏感度83.7%,特异度94.4%,AUC 0.93),且FLIS<5是CP A级患者首次肝功能失代偿的独立预测因子。

要点

  • FLIS由肝胆期肝实质强化、胆道排泄和门静脉信号强度三个参数构成,与CP评分强相关。
  • FLIS≥5可用于区分CP A级或慢性肝病与更晚期肝功能不全。
  • CP A级患者中FLIS<5提示首次失代偿风险显著增高。

关键影像表现/征象

  • 肝胆期图像评估三个参数:肝实质强化、胆道排泄和门静脉信号强度。
  • 患者分为慢性肝病(n=11)、CP A级(n=87)、CP B级(n=22)、CP C级(n=14)。

诊断标准与关键数值

  • FLIS与CP评分的相关系数r=-0.60至0.82(强至非常强相关)。
  • FLIS≥5预测CP A级或慢性肝病:敏感度83.7%,特异度94.4%,AUC 0.93。
  • CP A级患者中FLIS<5预测首次肝功能失代偿:HR 50.0(95%CI 6.2-400.4)。

临床应用与阅片要点

  • 在钆塞酸增强MRI肝胆期图像上评估FLIS三个参数,辅助无创评估肝功能分级。
  • 对CP A级患者,关注FLIS<5提示的失代偿风险,建议密切随访。

局限性

  • 回顾性研究设计。
  • 单中心样本量有限(n=134)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To validate the functional liver imaging score (FLIS) for prediction of hepatic function in gadoxetic acid-enhanced MRI.

METHODS: We retrospectively identified 134 patients (88 men, 46 women; mean age, 58.8 years) between January 2015 and December 2018 with the following inclusion criteria: patients diagnosed with liver cirrhosis or chronic liver disease (CLD) who underwent gadoxetic acid-enhanced MRI. Three parameters on hepatobiliary phase images were evaluated for FLIS: liver parenchymal enhancement, biliary excretion, and signal intensity of the portal vein. Patients were classified as CLD (n = 11), Child-Pugh (CP) class A (n = 87), CP B (n = 22), or CP C (n = 14). We assessed the correlation between CP score and both FLIS and its components using Spearman rank correlation. Receiver operating characteristic (ROC) curve analysis was performed to demonstrate the cutoff value of FLIS for differentiating between CP classes. The associations between patient characteristics, serum markers, FLIS, and hepatic decompensation were evaluated with Cox proportional hazard models.

RESULTS: FLIS and three FLIS parameters showed strong to very strong correlation with CP score (r = -0.60 to 0.82). ROC curve analysis showed that FLIS ≥ 5 was the optimal cutoff for prediction of CP class A or CLD (sensitivity, 83.7%; specificity, 94.4%; area under the curve [AUC], 0.93). FLIS < 5 was independently associated with the development of first hepatic decompensation in patients with CP A (HR, 50.0; 95% confidence interval, 6.2, 400.4).

CONCLUSION: FLIS showed a strong correlation with hepatic function and can stratify the CP class. In addition, FLIS can help prediction for the development of first decompensation.

KEY POINTS: • Functional liver imaging scores (FLIS) and its three parameters, derived from hepatobiliary phase image, have strong to very strong correlations with Child-Pugh (CP) scores. • FLIS can stratify patients with chronic liver disease or liver cirrhosis according to CP classification. • Low FLIS is an independent predictor for first hepatic decompensation in patients with CP class A.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee HJ, Hong SB, Lee NK, et al. Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS. Eur Radiol. 2021. PMID: 33881570. doi:10.1007/s00330-021-07955-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。